Wells Fargo Securities’ Ohsung Kwon expects artificial intelligence to dominate third-quarter earnings season. “Outside of AI, I’m not really excited about anything,” Kwon, the firm’s chief...
Johnson and Johnson is a buy as executives project strong medicine sales over the next two years and as the company expands its drug-making operations in...
